Ownership history in Qube Research & Technologies Ltd Β· 33 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in COGNIZANT TECHNOLOGY SOLUTIO (CTSH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Qube Research & Technologies Ltd underperformed the S&P 500 by β9.0% annually on this CTSH position. Timing score: 42% (13/31 decisions correct). Average cost basis: $67.98. Maximum drawdown during holding period: β39.9%.
β Significantly underperformed the S&P 500 by 9.0% ann.
31 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
13 of 31 add/trim decisions correct
Best entry: $54.15 (2022 Q3) Β· Worst: $82.58 (2025 Q4)
πͺ Held through 2 major drawdowns (>20%).
18 adds Β· 15 trims. Bought during 10 of 13 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size